From unexpected diagnosis to DIAGNODE-3 participant
Katie Howell was diagnosed with type 1 diabetes last year at age 25. Now, she's the first DIAGNODE-3 trial participant…
ATTD 2025: Closing the loop to cures
At ATTD 2025, Breakthrough T1D led sessions showcasing advancements in T1D cell therapies, early detection, and technology to improve lives.
From Breakthrough T1D trainee to Principal Investigator: Kelsey Voss, Ph.D., is calling the shots
Kelsey Voss, Ph.D., received Breakthrough T1D's Advanced Postdoctoral Fellowship Award, which helped start her lab at UVA studying T cells…
Shining the spotlight on Breakthrough T1D scientist Dr. Cassandra Bazile
Dr. Cassandra Bazile is a scientist at Breakthrough T1D who champions community, mentorship, and inclusion in STEM.
The extraordinary contributions of African Americans to healthcare
Join Breakthrough T1D in honoring African American pioneers who have made significant contributions to research, science, and healthcare.
Breakthrough T1D Mourns Tragic, Sudden Loss of Five Ride Champions
The leadership, staff, and volunteers of Breakthrough T1D mourn the recent loss of five T1D Champions.
A bittersweet goodbye for Sydney Yovic, Breakthrough T1D Chief Strategy Officer and Chief of Staff
A look back at her career here, and a look forward at her future as CEO of our Australia affiliate.
Meet Our New International Board of Directors Vice Chair, Matt Varey
Matt Varey, the newly elected Vice Chair of the Breakthrough T1D International Board of Directors (IBOD), brings a truly global…
Meet Our New International Board of Directors Chair, Lisa F. Wallack
Lisa F. Wallack, newly elected Chair of the Breakthrough T1D International Board of Directors, is carrying on her family's legacy…
